Upper Endoscopy in Cirrhotic Patients With Upper Gastrointestinal Bleeding

NCT ID: NCT06214234

Last Updated: 2024-01-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-01

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Liver cirrhosis is a common diffuse and persistent liver disease often accompanied by portal hypertension, liver failure, upper gastrointestinal bleeding (UGIB), and other complications. The incidence rate of liver cirrhosis with UGIB is as high as 30-40%, which is related to the rupture bleeding of gastroesophageal varices (GOV), hepatogenic ulcer, portal hypertensive gastropathy, hepatic gastrointestinal failure, etc

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the case of UGIB in patients with liver cirrhosis, acute peripheral circulatory failure may suddenly occur, resulting in decreased blood perfusion in liver tissues, often accompanied by clinical manifestations such as blood volume decline, melena, and haematemesis. This disease progresses rapidly, with a mortality rate of above 10% if not treated promptly

Timing of endoscopy in the management of acute upper gastrointestinal bleeding (AUGIB) has been a subject of perennial debate. Despite remarkable advancements in endoscopic treatments and substantial efforts in reducing mortality, the overall in-hospital mortality rate associated with UGIB is still estimated to be 10%.

Several studies have investigated the clinical impact of urgent (within 6 h of presentation) or early (within 12 h) endoscopy on mortality in patients with UGIB. Some studies showed no significant difference in mortality rate between urgent and elective endoscopy groups among high-risk patients with acute UGIB

In contrast, others found that urgent endoscopy was associated with a lower mortality rate in high-risk patients with acute non-variceal UGIB. Most of the previous studies included highly selected patients with non-variceal UGIB or those at a high risk. However, given that the definitive diagnosis is made after endoscopic examination, these studies may not reflect real-world clinical practice. Furthermore, it is often challenging to predict the cause of bleeding and to identify patients at high risk who require intensive care based on their symptoms and the information obtained in the emergency room

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Esophageal Varices

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two groups of patients present with variceal bleeding
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Investigators
Patient will be enrolled in one each group without masking

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early band ligation

Patients with liver cirrhosis present with variceal bleeding underwent band ligation within 12 hours of presentation

Group Type OTHER

Band ligation

Intervention Type PROCEDURE

Band ligation in variceal bleeding

Delayed band ligation

Patients with liver cirrhosis present with variceal bleeding underwent band ligation within more than 12 hours of presentation

Group Type OTHER

Band ligation

Intervention Type PROCEDURE

Band ligation in variceal bleeding

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Band ligation

Band ligation in variceal bleeding

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Any patient who is above age of 18 years old and with liver cirrhosis and present with UGIB will be eligible for the study

Exclusion Criteria

* Patients with age less than 18 years old
* Non-cirrhotic patients
* Patients with hemodynamic instability
* Patient's refusal
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Shadn Ahmed Keilany

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shaden Kelany, MSc

Role: STUDY_DIRECTOR

Assiut University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assiut University

Asyut, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Shaden Kelany, MSc

Role: CONTACT

01024817165 ext. 002

Ahmed M Abu-Elfatth, MD

Role: CONTACT

+18677791

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Shaden Kelany, MSc

Role: primary

01024817165 ext. 002

Ahmed M Abu-Elfatth, MD

Role: backup

+18677791

References

Explore related publications, articles, or registry entries linked to this study.

Kim J, Gong EJ, Seo M, Park JK, Lee SJ, Han KH, Kim YD, Jeong WJ, Cheon GJ, Seo HI. Timing of endoscopy in patients with upper gastrointestinal bleeding. Sci Rep. 2022 Apr 27;12(1):6833. doi: 10.1038/s41598-022-10897-3.

Reference Type BACKGROUND
PMID: 35477727 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Shadn Protocol

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.